![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 16, 14206-14210, April 19, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, October 1, 2001, and in revised form, January 30, 2002
Fundamental to the metabolic sensor function of
ATP-sensitive K+ (KATP) channels is the
sulfonylurea receptor. This ATP-binding cassette protein, which
contains nucleotide binding domains (NBD1 and NBD2) with conserved
Walker motifs, regulates the ATP sensitivity of the pore-forming Kir6.2
subunit. Although NBD2 hydrolyzes ATP, a property essential in
KATP channel gating, the role of NBD1, which has limited
catalytic activity, if at all, remains less understood. Here, we
provide functional evidence that cooperative interaction, rather than
the independent contribution of each NBD, is critical for
KATP channel regulation. Gating of cardiac KATP
channels by distinct conformations in the NBD2 ATPase cycle, induced by
Bifunctional protein complexes that combine catalytic and
conduction properties have been discovered recently (1-5). A
prototypic channel/enzyme multimer is the ATP-sensitive potassium
(KATP)1 channel
complex. Indeed, K+ permeation through the channel pore is
inhibited by direct binding of ATP to the Kir6.2 pore-forming subunit
and can be gated through an ATPase cycle within the sulfonylurea
receptor (SUR) subunit (3, 5-9). The central role for SUR in defining
the ATP sensitivity of KATP channels is underscored by the
abnormal cellular responses, associated with life-threatening disease,
that result from malfunction of this regulatory channel module (7-10).
In fact, the ATPase function of the SUR subunit has been proposed to
translate intracellular metabolic signals into membrane electrical
events (5, 11). However, the components of SUR responsible for signal
transduction within the KATP channel complex remain to be established.
As a member of the ATP-binding cassette (ABC) protein family, SUR
contains two consensus sequences for nucleotide binding and hydrolysis
known as nucleotide binding domains or NBDs (12-14). Both NBDs are
apparently required for optimal performance in ABC proteins (15, 16). A
deficit in one disrupts the function of the other domain and the ABC
protein as a whole, suggesting an interdependence of NBD functions
(17-19). In SUR, mutations in the conserved NBD1 Walker A motif
prevent ATP binding at both NBDs
(20)2 and interfere with the
stimulatory effect of KATP channel regulators, which act
through NBD2 (21-25). Conversely, MgADP at NBD2 promotes stabilization
of ATP at NBD1 indicating cooperative nucleotide binding at the NBDs of
KATP channels (6, 19, 26). NBD2 of SUR has been assigned
the role of ATP hydrolysis (3, 6, 19), and discrete conformations
driven by this intrinsic ATPase cycle have been identified as essential
in channel gating (5). In contrast, NBD1 has limited catalytic activity
(3), if at all (6, 19), and the role of this domain in KATP
channel gating remains less understood (21, 27, 28).
Here, we report that an intact NBD1 is mandatory for NBD2
ATPase-dependent KATP channel gating.
Stabilization of ATP at NBD1 depends on, and simultaneously promotes,
engagement of NBD2 into a MgADP-bound conformation required to
counteract ATP-induced pore closure. Thus, rather than individual
components of the regulatory subunit, it is the functional tandem
formed by NBD1 and NBD2 that drives SUR-mediated
nucleotide-dependent gating of the KATP channel complex.
ATPase Activity in NBD2--
The ATPase activity in the second
nucleotide binding domain (NBD2) of the cardiac sulfonylurea receptor
(SUR2A) was measured as described (3, 5). In brief, recombinant NBD2
(Gly1306-Thr1498) was purified from
Escherichia coli as a fusion to maltose binding protein
using affinity chromatography on an amylose resin in (mM) 600 NaCl, 1 EDTA, 20 Tris (pH 7.4), and 10% glycerol. Products of
[ Site-directed Mutagenesis--
Point mutations in the core
consensus sequence of the Walker motifs of NBD1 and NBD2 in the hamster
cardiac SUR isoform, SUR2A, were introduced in the pCDNA3.1 plasmid
by PCR amplification of both DNA strands with complementary primers
containing desired amino acid changes (QuickChange, Stratagene).
Primers were designed to contain 30 bases harboring the mutation in the
middle, with at least one base at the 3' end being C or G. Mutated
constructs were sequenced to confirm point mutations and rule out
additional changes in the sequence (3).
Transfection of Kir6.2 and SUR2A Clones--
COS-1 cells were
cultured in Dulbecco's modified Eagle's medium with 10% fetal calf
serum plus 2 mM glutamine and seeded at 2 × 106 cells prior to transfection. Kir6.2, with wild-type or
mutated SUR2A, were subcloned into the expression vector pCDNA3.1
(5, 14). COS cells were transiently transfected with plasmids using LipofectAMINE 2000 (Invitrogen). pCDNA3.1-SUR2A (10 µg)
and pCDNA3.1-Kir6.2 (1 µg) were included with the expression
vector for green fluorescent protein (0.5 µg of pGREEN-lantern,
Invitrogen) used as a reporter gene.
Electrophysiological Measurements--
Channel behavior was
recorded in isolated ventricular myocytes dissociated from guinea pig
hearts (29) as well as in COS-1 cells expressing recombinant
KATP channels (5). Pipettes (~7-10 M Nucleotide Occlusion Procedures--
In conjunction with current
recording, two established approaches (30-34) were employed to trap
nucleotides within the catalytic site of the KATP channel
ATPase. First, NBD1 Mandatory for NBD2-dependent KATP
Channel Gating--
Engagement of the NBD2 ATPase cycle into discrete
conformations determines KATP channel behavior (5). In this
regard, ATP Stabilized at NBD1 Is Necessary for
NBD2-dependent KATP Channel Gating--
MgADP
at NBD2 promotes KATP channel opening (5) and concomitantly
stabilizes ATP at NBD1 even in the absence of Functional Tandem of NBD1 and NBD2 Secures KATP Channel
Gating--
The cooperative binding of nucleotides at the NBDs of
KATP channels (6, 19, 26) suggests a joint action of NBD1
and NBD2 on channel gating. Disruption of either NBD1 or NBD2 through mutation precluded the reduction in ATP-sensitivity observed after cooling in wild-type Kir6.2/SUR2A KATP channels (Fig.
3A). Specifically, mutations
in the Walker motifs of NBD2 (K1349A and/or D1470N), which diminish the
intrinsic ATPase activity (3), attenuated KATP channel
activation following cooling (Fig. 3B). The time course of
KATP channel activation was fitted by the Boltzmann's function, Imax·[1 + exp((T0.5 In the hetero-octameric KATP channel complex (35), the
sulfonylurea receptor confers fine nucleotide modulation of
K+ permeation through the channel pore (7-14). In fact,
the powerful metabolic sensor role of KATP channels may
stem from the nonequivalent properties of NBD1 and NBD2 recognized
within SUR (6, 19-22, 26). NBD1 has been demonstrated to bind
nucleotides, whereas NBD2 hydrolyzes ATP (6, 19, 20, 26); yet the
individual and/or collective contribution of NBDs in KATP
channel gating is not fully understood. In this study, we provide
functional evidence that cooperative interaction rather than the
independent contribution of each NBD is critical for KATP
channel regulation. These findings provide a paradigm for
KATP channel gating based on the integration of both NBDs
into a functional unit within the multimeric channel complex.
Specifically, although gating of cardiac KATP channels was
related to discrete conformations in the ATPase cycle at NBD2 (5), it
is now shown that the intactness of NBD1 is critical for this function.
In agreement with cooperative binding of nucleotides to SUR, where
MgADP at NBD2 promotes stabilization of ATP at NBD1 (6, 19), here ATP,
but not ADP, at NBD1 was required to promote MgADP-induced opening of
KATP channels in the presence of normally inhibitory
concentrations of ATP.
The requirement for "cross-talk" between NBDs appears to be a
common feature of several members of the ABC family. In fact, mutations
of p-glycoprotein that preclude nucleotide binding or arrest
ATP hydrolysis at one NBD prevent normal function at the other NBD (18,
34, 36-38). Moreover, ATP hydrolysis at both NBDs is necessary for
transport of a single molecule in the p-glycoprotein transport cycle (16, 38). In the cystic fibrosis transmembrane regulator, the close proximity of NBDs (39) permits nucleotide hydrolysis at one NBD to influence nucleotide binding at the other NBD
site, thereby regulating chloride conductance (40). Crystal structures
of ABC-related proteins (such as the HisP of histidine permease, MalK
of the trehalose/maltose transporter or the Mre11/Rad50-ATPase DNA
repair complex) suggest dimerization of the two NBDs with transfer of
mechanical energy from one NBD to the other within the protein
architecture (41-43). In this process, ATP binding has been found
critical in engaging the two NBD domains into a compact dimer essential
for supporting hydrolysis-dependent protein function (42).
Specifically, ATP binding has been proposed to bring the ATPase domain
into a position that ultimately contributes to the
"signaling-competent state" of the protein complex (43, 44). Thus,
by analogy, it is conceivable that ATP binding to NBD1 of SUR is a
necessary step in securing the proper structural arrangement of NBD2
required to translate conformational transitions during the ATPase
cycle into KATP channel gating. This is in accord with the
recent suggestion that the SUR NBD1 in its ATP-bound state directly
interacts with the pore-forming Kir6.2 subunit of the KATP
channel, counteracting ATP-induced channel inhibition (45).
In a cell in the basal metabolic state, ATP exceeds ADP concentration
such that ATP should always be bound to NBD1, whereas hydrolysis of ATP
would produce MgADP at NBD2 (Fig. 4).
Although this nucleotide combination should in principle be associated with channel opening (6, 19), in a cardiac cell KATP
channels are normally closed (Fig. 4). Indeed, despite continuous
ATPase activity at NBD2, the product of ATP hydrolysis is rapidly
removed by cellular ADP-scavenging systems, such as that catalyzed by creatine kinase, limiting the lifetime of the MgADP-bound conformation and preventing channel opening (5, 11, 46, 47) (Fig. 4). However, under
metabolic stress, which suppresses creatine kinase activity (48), ADP
will increase at the channel site (5). A prolonged lifetime of the
MgADP-bound conformation promotes ATP stabilization at NBD1 and thereby
channel opening (5, 6, 19) (Fig. 4).
Although here we employed temperature to cooperatively stabilize the
MgADP-bound conformation of NBD2 and ATP at NBD1 (19, 30), such a
phenomenon may actually be relevant in nature as well. Indeed,
KATP channel behavior has been studied in cardiac myocytes
from goldfish that had been acclimated to low temperatures (7 °C) as
used in this study (49). KATP channels from these animals
were nearly insensitive to concentrations of ATP that were completely
inhibitory in non-cold-acclimated animals (49). This observation is
given a mechanistic basis by the present data, which suggest that
membrane cooling promotes cooperative nucleotide stabilization at NBDs
resulting in reduction of the channel's ATP sensitivity. The resulting
alteration in channel activity is proposed to promote survival at low
temperature by membrane potential clamping, as well as maintenance of
ionic and energetic homeostasis (49). Moreover, in mammals, a
cardioprotective effect of KATP channels is also present at
low temperature, and this effect has been exploited in cardioplegia
procedures (50). Thus, the results of the current study provide a
working model of KATP channel function and point to
potential avenues in addressing the biology of cold tolerance (51).
We are grateful to Drs. K. Ueda and M. Matsuo
for the critical reading of this manuscript and for giving us
permission to refer to their unpublished work. We thank Drs. J. Bryan,
Y. Kurachi, and S. Seino for providing KATP channel clones.
*
This work was supported by National Institutes of Health
Grants HL-64822 and HL-07111, the American Heart Association, the Miami
Heart Research Institute, the American Physicians Fellowship for
Medicine in Israel, the Bruce and Ruth Rappaport Program in Vascular
Biology and Gene Delivery, and the Marriott Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
An Established Investigator of the American Heart Association.
To whom correspondence should be addressed. Tel.: 507-284-2747; Fax:
507-84-9111; E-mail: terzic.andre@mayo.edu.
Published, JBC Papers in Press, February 1, 2002, DOI 10.1074/jbc.M109452200
2
K. Ueda and M. Matsuo, personal communication.
These authors observed no ATP binding to NBD2 following mutation of the
conserved lysine residue in the NBD1 Walker A motif of SUR1 isoform.
The abbreviations used are:
KATP, ATP-sensitive K+;
NBD, nucleotide binding domain(s);
SUR, sulfonylurea receptor;
ABC, ATP-binding cassette;
BeFx, beryllium fluoride
Tandem Function of Nucleotide Binding Domains Confers Competence
to Sulfonylurea Receptor in Gating ATP-sensitive
K+ Channels*
,
,
,
,
,
§, and
¶
Division of Cardiovascular Diseases,
Departments of Medicine, Molecular Pharmacology, and Experimental
Therapeutics, Mayo Clinic, Mayo Foundation, Rochester, Minnesota 55905 and the § Institute of Theoretical and Experimental
Biophysics, Russian Academy of Sciences,
142290 Puschino, Russia
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-phosphate analogs, was disrupted by point mutation not only of the
Walker motif in NBD2 but also in NBD1. Cooling membrane patches to
decelerate the intrinsic ATPase activity counteracted ATP-induced
KATP channel inhibition, an effect that mimicked
stabilization of the MgADP-bound posthydrolytic state at NBD2 by the
-phosphate analog orthovanadate. Temperature-induced channel
activation was abolished by mutations that either prevent stabilization
of MgADP at NBD2 or ATP at NBD1. These findings provide a paradigm of
KATP channel gating based on integration of both NBDs into
a functional unit within the multimeric channel complex.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-32P]ATP hydrolysis, measured in (mM) 34 KCl, 8 MgCl2, 50 HEPES (pH 7.4), 4 ATP, and 10% glycerol
(1 h, 37 °C), were then resolved by polyethyleneimine thin layer
chromatography (Cellulose PEI TLC, Sigma) in 0.75 M
KH2PO4 (pH 4.8). ATPase activity of NBD2 (10 µg) was quantified with a PhosphorImager and ImageQuant software (Molecular Dynamics).
) were
filled with (in mM) KCl 140, CaCl2 1, MgCl2 1, HEPES-KOH 5 (pH 7.3). For the inside-out
configuration, cells were superfused with "internal solution" (in
mM) KCl 140, MgCl2 1, EGTA 5, HEPES-KOH 5 (pH
7.3). For the open cell-attached patch, internal solution was
supplemented with glucose (1 g/liter), malic acid (5 mM), and pyruvic acid (5 mM). Following seal formation, the open
cell-attached configuration was obtained by applying digitonin (8 µg/ml) through a second pipette (filled with 5 µg/ml propidium
iodide and 0.5 µg/ml rhodamine). Solution flow was visualized by
rhodamine under ultraviolet light, and staining of the cell nucleus
with propidium iodide served as a criterion for plasmalemmal
permeabilization. Data were expressed as means ± S.E.
-phosphate analogs, orthovanadate and beryllium
fluoride, were used to stabilize MgADP in the post- and prehydrolytic
states of SUR, respectively (5, 32-34). To this end, sodium vanadate
(100 mM, Sigma) was dissolved in water (pH 10), and
orthovanadate was obtained by boiling the vanadate solution (pH 10).
Freshly boiled stock was diluted to final concentration (pH 7.3) prior
to use. Beryllium fluoride (BeF2), as a 33% stock solution
(Alfa), was dissolved in buffer solution containing 50 mM
KF to produce sufficient amount of phosphate analogs
BeFx (BeF

-phosphate analogs by cooling down the membrane patch
after formation of the occluded nucleotide at >30 °C (30). In these
experiments we used a heating/cooling bath temperature controller
(HCC-100A, Dagan Corp.) equipped with an electronically controlled high
precision (±0.1 °C) and broad range Peltier thermocouple set
between 4 and 32 °C.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-phosphate analogs, orthovanadate and beryllium
fluoride, are valuable tools that arrest the ATPase cycle in distinct
conformations by stabilizing MgADP at the catalytic site (32-34).
Here, ATPase activity in recombinant NBD2 was 77.6 ± 3.9 nmol
Pi/min/mg (n = 11) and was suppressed to
17.4 ± 2.8 (n = 11) and 6.4 ± 2.2 (n = 4) nmol Pi/min/mg by 1 mM
orthovanadate and beryllium fluoride, respectively (Fig. 1A). Vigorous activation of
ATP-inhibited wild-type recombinant KATP channels
(Kir6.2/SUR2A, Fig. 1C) produced by orthovanadate through stabilization of NBD2 in a MgADP-bound post-hydrolytic conformation (5) was disrupted not only by mutations in NBD2 but also
in NBD1 (Fig. 1, B and E). Specifically,
orthovanadate-induced KATP channel opening was abolished
either by replacing aspartate with asparagine in the Walker B motif of
the SUR2A NBD2 (D1470N), a mutation that disrupts ATP hydrolysis (3,
32), or by exchanging lysine for alanine in the Walker A motif of NBD1
(K708A), which precludes ATP binding to SUR1 (20; Fig. 1, B
and E). On average, channel activity in the presence of 0.25 mM ATP and 1 mM orthovanadate was in the wild
type 72 ± 18% of maximal channel opening measured in the absence
of ATP (n = 4; Fig. 1B). It was reduced to
5 ± 3% in the D1470N mutant and to 3 ± 1% in the K708A
mutant (n = 4; Fig. 1B). Similarly, either
the D1470N or the K708A mutation reversed the inhibitory effect of
beryllium fluoride (Fig. 1, B, D, and
E), which traps the NBD2 ATPase in a prehydrolytic ATP-like bound state (5). Accordingly, KATP channel activity in the presence of 0.1 mM MgADP and 1 mM BeFx
was in wild-type, D1470N, and K708A mutants, respectively, 8 ± 2%, 63 ± 14%, and 79 ± 10% of the maximal activity
measured in the absence of nucleotide (n = 3; Fig.
1B). Thus, an intact NBD1 is required for the NBD2 ATPase
dependent KATP channel gating.

View larger version (49K):
[in a new window]
Fig. 1.
Nucleotide binding domains of SUR2A required
for KATP channel gating by
-phosphate analogs. A,
-phosphate analogs orthovanadate (ortho-V, 1 mM) or BeFx (1 mM) inhibit ATPase
activity in recombinant NBD2. B, average channel activity of
Kir6.2 co-expressed in COS-1 cells with wild-type SUR2A or with SUR2A
mutated in either NBD2 (aspartate to asparagine, D1470N) or NBD1
(lysine to alanine, K708A) in the presence of
-phosphate analogs,
orthovanadate (1 mM) plus ATP (0.25 mM) and
BeFx (1 mM) plus ADP (0.1 mM),
respectively. Channel activity was expressed relative to control
activity measured in the absence of ATP or ADP for orthovanadate
(n = 5) and BeFx (n = 4),
respectively. C, vigorous opening of wild-type
(wt) Kir6.2/SUR2A channels visualized in inside-out patches
as a downward deflection relative to the zero current level
(dotted line). Recombinant channel activity was readily
inhibited by ATP (0.25 mM). ATP-induced channel inhibition
was reversed by the
-phosphate analog orthovanadate, an effect that
required 14.2 ± 0.3 min (n = 5) to reach maximal
effect. During the 3-min-long break, no change in channel activity was
observed. D, in contrast to orthovanadate, beryllium
fluoride (BeFx = BeF2 + KF 50 mM) did
not antagonize ATP-induced channel inhibition. Rather, in the presence
of Mg2+ and ADP, BeFx inhibited Kir6.2/SUR2A
channel opening. E, mutation (K708A) in the NBD1 Walker A
motif of SUR2A prevented the effect of both orthovanadate and
BeFx on KATP channels. During the 12-min-long
break, no change in channel activity was observed.
-phosphate analogs (6,
19, 26). Whether such stabilization of ATP at NBD1 is required for
NBD2-dependent channel gating has not been resolved thus
far, as the lifetime of the MgADP-bound conformation is limited because
of dissociation from NBD2 (5, 19, 26). To slow ATPase activity and
promote the lifetime of MgADP at the catalytic site, we cooled membrane
patches and monitored KATP channel behavior on-line. ATP
inhibition of KATP channels (at >30 °C) was reversed by
transient cooling (to 5 °C) of membrane patches (Fig.
2A). On average, in inside-out
patches (Fig. 2B, upper panel) ATP-induced channel
inhibition was markedly reduced from an initial IC50 of
25 ± 1.4 µM (n = 5-12) to 0.7 ± 0.1 mM (n = 2-5) following the cooling
interval. Similarly, in open cell-attached patches (Fig. 2B,
lower panel), a distinct patch condition, the sensitivity of
KATP channels toward ATP was reduced from an initial IC50 of 270 ± 21 µM (n = 6-14) to 1.6 ± 0.2 mM (n = 2-7)
after cooling. In contrast, cooling-induced KATP channel
activation was not achieved in the presence of poorly hydrolyzable ATP
analogs, AMP-PNP (n = 5; Fig. 2C) or
Ap4A (n = 3; Fig. 2D). Thus,
cooling does not disrupt hydrolysis-independent KATP
channel gating but rather promotes MgADP stabilization at the catalytic
site (30), which in turn is essential for channel opening. Although
MgADP can be stabilized at NBD2 (5), excluding ATP, by application of
the ADP-regenerating system hexokinase plus glucose prevented cooling-induced reduction of KATP channel sensitivity to
ATP (Fig. 2E). This suggests that the presence of ATP at
NBD1 is a prerequisite for MgADP to serve as a KATP channel
regulator at NBD2. Indeed, in the same patch, cooling performed in the
presence of ATP induced KATP channel opening, which was
abolished by activation of the ADP-scavenging creatine
phosphate/creatine kinase system (Fig. 2E). Therefore,
cooperative stabilization of ATP and MgADP at NBDs translates into
KATP channel opening at inhibitory levels of ATP.

View larger version (37K):
[in a new window]
Fig. 2.
Cooling-induced activation of
KATP channels requires both MgADP and ATP.
A, in a cardiomyocyte, in the open cell-attached patch
configuration, native KATP channels were inhibited by 0.25 mM ATP. Transient cooling of the membrane patch (to
6 °C) reversed ATP-induced KATP channel inhibition.
B, on average, the cooling interval (4-8 °C) produced a
significant rightward shift in the ATP-dependent
KATP channel inhibition in inside-out (upper
panel) and open cell-attached (lower panel) patches.
The solid lines represent Hill plots reconstructed based on
parameters obtained by fitting experimental points. Cooling
failed to activate KATP channels inhibited by the
nonhydrolyzable ATP analogs AMP-PNP (C) or Ap4A
(D). In the same patches, replacing AMP-PNP or
Ap4A with ATP reversed KATP channel inhibition
following cooling. E, KATP channel inhibition by
0.5 mM ATP was partially antagonized by MgADP (38 ± 7% of control activity in the absence of nucleotides,
n = 3). Then, 0.5 mM ADP was clamped in the
presence of the ATP-scavenging hexokinase/glucose system. Following the
cooling interval, the sensitivity of KATP channel toward
ATP plus MgADP (44 ± 9% of control, n = 3) as
well as the sensitivity of channels to ATP alone were not significantly
changed. In the same patch, cooling in the presence of MgATP
antagonized channel inhibition (84 ± 6% of control activity,
n = 3), an effect reversed by activation of the
ADP-scavenging creatine kinase/creatine phosphate (CrP)
system. All experiments were performed in open cell-attached patches.
The temperature gradient is shown by a color bar on top of
records.
t)/k)]
1, where
Imax is the maximal channel activity expressed
relative to the activity in the absence of ATP,
T0.5 the time of half-activation, t
the relative time of reheating, and k the slope of the time course. In wild-type Kir6.2/SUR2A channels, parameters defining the
time course were as follows: Imax = 1.12 ± 0.04, T0.5 = 0.60 ± 0.03, and
k = 0.24 ± 0.03 (n = 3; Fig.
3D). The K1349A/D1470N mutations significantly decreased and
delayed activation of KATP channels
(Imax = 0.42 ± 0.04, T0.5 = 0.92 ± 0.05, k = 0.16 ± 0.04, n = 3; Fig. 3D).
Furthermore, the K708A mutation that prevents ATP binding to NBD1 (20)
also abolished KATP channel activation (n = 3; Fig. 3, C and D). Thus, disrupting either NBD1
or NBD2 impedes KATP channel opening upon cooling,
indicating that NBDs act as a functional unit rather than as
independent determinants of channel gating.

View larger version (40K):
[in a new window]
Fig. 3.
Intact NBD1 and NBD2 of SUR2A necessary for
cooling induced KATP channel opening. A, in
an inside-out patch, ATP-induced inhibition of wild-type
(w.t.) Kir6.2/SUR2A channels, was reversed by a cooling
period. B, mutations in Walker A (1349 lysine to alanine)
and B (1470 aspartate to asparagine) motifs of NBD2 in the SUR2A
subunit (K1349A/D1470N) significantly reduced ATP-induced inhibition of
recombinant KATP channels following cooling. C,
mutation of the Walker A (708 lysine to alanine) domain of NBD1 in
SUR2A (K708A) abolished the antagonism of ATP-induced KATP
channel inhibition following cooling. In A-C, the
temperature gradient is shown by a color bar
above the records. D, average activation time
course of wild-type (WT) or mutated recombinant
KATP channels expressed relative to control activity
measured in the absence of ATP. Time of activation was normalized to
the time required for heating a particular membrane patch from 7 to
30 °C. Solid lines represent Boltzmann's curves
constructed using parameters described in the text.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (27K):
[in a new window]
Fig. 4.
KATP channels gated through
interaction between nucleotide binding domains of the SUR subunit.
A "bird's eye view" of the hetero-octameric KATP
channel complex composed of four pore-forming Kir6.2 and four
regulatory SUR subunits, which possess two nucleotide-binding domains,
NBD1 and NBD2. Under basal metabolic state (in the presence of high
levels of intracellular ATP), ATP is bound to NBD1 and hydrolyzed at
NBD2 by the intrinsic ATPase. Under this condition, the ADP-scavenging
creatine kinase (CK) system prevents accumulation of ADP at
the channel site and perpetuates the ATPase cycle impeding ATP
stabilization at NBD1. Under metabolic stress, a drop in ATP
regeneration increases MgADP at the channel site (5, 11) and prolongs
the lifetime of the MgADP-bound conformation at NBD2 leading to
entrapment of ATP at NBD1 and channel opening. Cooling and the
-phosphate analog orthovanadate (ortho-V) also induce
channel activation by promoting cooperative nucleotide interactions at
NBDs.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
-phosphate analog;
AMP-PNP, adenosine
5'-(
,
-imino)triphosphate;
Ap4A, diadenosine tetraphosphate.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Gulbis, J. M.,
Mann, S.,
and MacKinnon, R.
(1999)
Cell
97,
943-952[CrossRef][Medline]
[Order article via Infotrieve] 2.
Banfi, B.,
Maturana, A.,
Jaconi, S.,
Arnaudeau, S.,
Laforge, T.,
Sinha, B.,
Ligeti, E.,
Demaurex, N.,
and Krause, K. H.
(2000)
Science
287,
138-142 3.
Bienengraeber, M.,
Alekseev, A. E.,
Abraham, M. R.,
Carrasco, A. J.,
Moreau, C.,
Vivaudou, M.,
Dzeja, P. P.,
and Terzic, A.
(2000)
FASEB J.
14,
1943-1952 4.
Runnels, L. W.,
Yue, L.,
and Clapham, D. E.
(2001)
Science
291,
1043-1047 5.
Zingman, L. V.,
Alekseev, A. E.,
Bienengraeber, M.,
Hodgson, D.,
Karger, A. B.,
Dzeja, P. P.,
and Terzic, A.
(2001)
Neuron
31,
233-245[CrossRef][Medline]
[Order article via Infotrieve] 6.
Matsuo, M.,
Kioka, N.,
Amachi, T.,
and Ueda, K.
(1999)
J. Biol. Chem.
274,
37479-37482 7.
Nichols, C. G.,
Shyng, S.,
Nestorowicz, A.,
Glaser, B.,
Clement, J.,
Gonzalez, G.,
Aguilar-Bryan, L.,
Permutt, M.,
and Bryan, J.
(1996)
Science
272,
1785-1787[Abstract] 8.
Bryan, J.,
and Aguilar-Bryan, L.
(1999)
Biochim. Biophys. Acta
1461,
285-303[Medline]
[Order article via Infotrieve] 9.
Seino, S.
(1999)
Annu. Rev. Physiol.
61,
337-362[CrossRef][Medline]
[Order article via Infotrieve] 10.
Abraham, M. R.,
Jahangir, A.,
Alekseev, A. E.,
and Terzic, A.
(1999)
FASEB J.
13,
1901-1910 11.
Carrasco, A. J.,
Dzeja, P. P.,
Alekseev, A. E.,
Pucar, D.,
Zingman, L. V.,
Abraham, M. R.,
Hodgson, D.,
Bienengraeber, M.,
Puceat, M.,
Janssen, E.,
Wieringa, B.,
and Terzic, A.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
7623-7628 12.
Aguilar-Bryan, L.,
Nichols, C.,
Wechsler, S.,
Clement, J.,
Boyd, A.,
Gonzalez, G.,
Herrerasosa, H.,
Nguy, K.,
Bryan, J.,
and Nelson, D.
(1995)
Science
268,
423-426 13.
Inagaki, N.,
Gonoi, T.,
Clement, J. P.,
Namba, N.,
Inazawa, J.,
Gonzalez, G.,
Aguilar-Bryan, L.,
Seino, S.,
and Bryan, J.
(1995)
Science
270,
1166-1170 14.
Inagaki, N.,
Gonoi, T.,
Clement, J. P.,
Wang, C. Z.,
Aguilar-Bryan, L.,
Seino, S.,
and Bryan, J.
(1996)
Neuron
16,
1011-1017[CrossRef][Medline]
[Order article via Infotrieve] 15.
Senior, A. E.,
and Gadsby, D. C.
(1997)
Semin. Cancer Biol.
8,
143-150[CrossRef][Medline]
[Order article via Infotrieve] 16.
Sauna, Z. E.,
and Ambudkar, S. V.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
2515-2520 17.
Ueda, K.,
Matsuo, M.,
Tanabe, K.,
Morita, K.,
Kioka, N.,
and Amachi, T.
(1999)
Biochim. Biophys. Acta
1461,
305-313[Medline]
[Order article via Infotrieve] 18.
Urbatsch, I. L.,
Beaudet, L.,
Carrier, I.,
and Gros, P.
(1998)
Biochemistry
37,
4592-4602[CrossRef][Medline]
[Order article via Infotrieve] 19.
Matsuo, M.,
Tanabe, K.,
Kioka, N.,
Amachi, T.,
and Ueda, K.
(2000)
J. Biol. Chem.
275,
28757-28763 20.
Ueda, K.,
Inagaki, N.,
and Seino, S.
(1997)
J. Biol. Chem.
272,
22983-22986 21.
Shyng, S.-L.,
Ferrigni, T.,
and Nichols, C. G.
(1997)
J. Gen. Physiol.
110,
643-654 22.
Gribble, F. M.,
Tucker, S. J.,
and Ashcroft, F. M.
(1997)
EMBO J.
16,
1145-1152[CrossRef][Medline]
[Order article via Infotrieve] 23.
D'hahan, N.,
Moreau, C.,
Prost, A. L.,
Jacquet, H.,
Alekseev, A. E.,
Terzic, A.,
and Vivaudou, M.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
12162-12167 24.
Babenko, A. P.,
Gonzalez, G.,
and Bryan, J.
(2000)
J. Biol. Chem.
275,
717-720 25.
Matsuoka, T.,
Matsushita, K.,
Katayama, Y.,
Fujita, A.,
Inageda, K.,
Tanemoto, M.,
Inanobe, A.,
Yamashita, S.,
Matsuzawa, Y.,
and Kurachi, Y.
(2000)
Circ. Res.
87,
873-880 26.
Ueda, K.,
Komine, J.,
Matsuo, M.,
Seino, S.,
and Amachi, T.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
1268-1272 27.
Matsuo, M.,
Trapp, S.,
Tanizawa, Y.,
Kioka, N.,
Amachi, T.,
Oka, Y.,
Ashcroft, F. M.,
and Ueda, K.
(2000)
J. Biol. Chem.
275,
41184-41191 28.
Gribble, F. M.,
Reimann, F.,
Ashfield, R.,
and Ashcroft, F. M.
(2000)
Mol. Pharmacol.
57,
1256-1261 29.
Alekseev, A. E.,
Brady, P. A.,
and Terzic, A.
(1998)
J. Gen. Physiol.
111,
381-394 30.
Szabo, K.,
Szakacs, G.,
Hegeds, T.,
and Sarkadi, B.
(1999)
J. Biol. Chem.
274,
12209-12212 31.
Goldstein, G.
(1964)
Anal. Chem.
36,
243-244 32.
Hrycyna, C. A.,
Ramachandra, M.,
Germann, U. A.,
Cheng, P. W.,
Pastan, I.,
and Gottesman, M. M.
(1999)
Biochemistry
38,
13887-13899[CrossRef][Medline]
[Order article via Infotrieve] 33.
Sankaran, B.,
Bhagat, S.,
and Senior, A. E.
(1997)
Biochemistry
36,
6847-6853[CrossRef][Medline]
[Order article via Infotrieve] 34.
Takada, Y.,
Yamada, K.,
Taguchi, Y.,
Kino, K.,
Matsuo, M.,
Tucker, S. J.,
Komano, T.,
Amachi, T.,
and Ueda, K.
(1998)
Biochim. Biophys. Acta
1373,
131-136[Medline]
[Order article via Infotrieve] 35.
Clement, J. P.,
Kunjilwar, K.,
Gonzalez, G.,
Schwanstecher, M.,
Panten, U.,
Aguilar-Bryan, L.,
and Bryan, J.
(1997)
Neuron
18,
827-838[CrossRef][Medline]
[Order article via Infotrieve] 36.
Beaudet, L.,
Urbatsch, I. L.,
and Gros, P.
(1998)
Biochemistry
37,
9073-9082[CrossRef][Medline]
[Order article via Infotrieve] 37.
Senior, A. E.,
and Bhagat, S.
(1998)
Biochemistry
37,
831-836[CrossRef][Medline]
[Order article via Infotrieve] 38.
Sauna, Z. E.,
and Ambudkar, S. V.
(2001)
J. Biol. Chem.
276,
11653-11661 39.
Qu, Q.,
and Sharom, F. J.
(2001)
Biochemistry
40,
1413-1422[CrossRef][Medline]
[Order article via Infotrieve] 40.
Gadsby, D. C.,
and Nairn, A. C.
(1999)
Physiol. Rev.
70,
77-107 41.
Jones, P. M.,
and George, A. M.
(1999)
FEMS Microbiol. Lett.
179,
187-202[CrossRef][Medline]
[Order article via Infotrieve] 42.
Diederichs, K.,
Diez, J.,
Greller, G.,
Muller, C.,
Breed, J.,
Schnell, C.,
Vonrhein, C.,
Boos, W.,
and Welte, W.
(2000)
EMBO J.
19,
5951-5961[CrossRef][Medline]
[Order article via Infotrieve] 43.
Hopfner, K. P.,
Karcher, A.,
Craig, L.,
Woo, T. T.,
Carney, J. P.,
and Tainer, J. A.
(2001)
Cell
105,
473-485[CrossRef][Medline]
[Order article via Infotrieve] 44.
Karpowich, N.,
Martsinkevich, O.,
Mille, L.,
Yuan, Y.-R.,
Dai, P. L.,
MacVey, K.,
Thomas, P. J.,
and Hunt, J. F.
(2001)
Structure
9,
571-586[Medline]
[Order article via Infotrieve] 45.
John, S. A.,
Weiss, J. N.,
and Ribalet, B.
(2001)
J. Gen. Physiol.
118,
391-406 46.
Weiss, J. N.,
and Lamp, S. T.
(1987)
Science
238,
67-69 47.
Dzeja, P. P.,
and Terzic, A.
(1998)
FASEB J.
12,
523-529 48.
Pucar, D.,
Dzeja, P. P.,
Bast, P.,
Juranic, N.,
Macura, S.,
and Terzic, A.
(2001)
J. Biol. Chem.
276,
44812-44819 49.
Ganim, R. B.,
Peckol, E. L.,
Larkin, J.,
Ruchhoeft, M. L.,
and Cameron, J. S.
(1998)
Comp. Biochem. Physiol.
119,
395-401 50.
Kevelaitis, E.,
Peynet, J.,
Mouas, C.,
Launay, J. M.,
and Menasche, P.
(1999)
Circulation
99,
3079-3085 51.
Azzam, N. A.,
Hallenbeck, J. M.,
and Kachar, B.
(2000)
Nature
407,
317-318[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Aguilar-Bryan and J. Bryan Neonatal Diabetes Mellitus Endocr. Rev., May 1, 2008; 29(3): 265 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-H. Xie, S. A. John, B. Ribalet, and J. N. Weiss Phosphatidylinositol-4,5-bisphosphate (PIP2) regulation of strong inward rectifier Kir2.1 channels: multilevel positive cooperativity J. Physiol., April 1, 2008; 586(7): 1833 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Karger, S. Park, S. Reyes, M. Bienengraeber, R. B. Dyer, A. Terzic, and A. E. Alekseev Role for SUR2A ED Domain in Allosteric Coupling within the KATP Channel Complex J. Gen. Physiol., February 25, 2008; 131(3): 185 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Burke, R. K. Mutharasan, and H. Ardehali The Sulfonylurea Receptor, an Atypical ATP-Binding Cassette Protein, and Its Regulation of the KATP Channel Circ. Res., February 1, 2008; 102(2): 164 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Zingman, A. E. Alekseev, D. M. Hodgson-Zingman, and A. Terzic ATP-sensitive potassium channels: metabolic sensing and cardioprotection J Appl Physiol, November 1, 2007; 103(5): 1888 - 1893. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gumina, D. F. O'Cochlain, C. E. Kurtz, P. Bast, D. Pucar, P. Mishra, T. Miki, S. Seino, S. Macura, and A. Terzic KATP channel knockout worsens myocardial calcium stress load in vivo and impairs recovery in stunned heart Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1706 - H1713. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamada, G. C. Kane, A. Behfar, X.-K. Liu, R. B. Dyer, R. S. Faustino, T. Miki, S. Seino, and A. Terzic Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant J. Physiol., December 15, 2006; 577(3): 1053 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jons, D. Wittschieber, A. Beyer, C. Meier, A. Brune, A. Thomzig, G. Ahnert-Hilger, and R. W. Veh K+-ATP-channel-related protein complexes: potential transducers in the regulation of epithelial tight junction permeability J. Cell Sci., August 1, 2006; 119(15): 3087 - 3097. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tammaro, P. Proks, and F. M. Ashcroft Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels J. Physiol., February 15, 2006; 571(1): 3 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Prasad, A. S. Al-Dadah, G. D. Byrd, T. P. Flagg, J. Gomes, R. J. Damiano Jr, C. G. Nichols, and J. S. Lawton Role of the Sarcolemmal Adenosine Triphosphate-Sensitive Potassium Channel in Hyperkalemic Cardioplegia-Induced Myocyte Swelling and Reduced Contractility Ann. Thorac. Surg., January 1, 2006; 81(1): 148 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Proks, C. Girard, and F. M. Ashcroft Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP Hum. Mol. Genet., September 15, 2005; 14(18): 2717 - 2726. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Hodgson, A. Behfar, L. V. Zingman, G. C. Kane, C. Perez-Terzic, A. E. Alekseev, M. Puceat, and A. Terzic Stable benefit of embryonic stem cell therapy in myocardial infarction Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H471 - H479. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Paajanen and M. Vornanen Regulation of action potential duration under acute heat stress by IK,ATP and IK1 in fish cardiac myocytes Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R405 - R415. [Abstract] [Full Text] [PDF] |
||||